Final decisions on the proposed, $18 million
operational budget for the California stem cell agency has been
delayed until some time in June in order to give the agency 's new
president, Randy Mills, time to put his mark on it.
The governing board's Finance
Subcommittee has scheduled a meeting for June 5 to re-examine the
plan. The panel took a first look at it earlier this month. Following
action by the subcommittee, the spending plan will go to the full
board. No date has been set for that session.
Details of the new version of the
budget are not publicly available. When they are posted on the agenda
for the June 5 meeting, they may give some sense of Mills' priorities.
No comments:
Post a Comment